Ivermectin inhibits cell proliferation and the expression levels of type I collagen, α‑SMA and CCN2 in hypertrophic scar fibroblasts

  • Authors:
    • Song Tian
    • Yongjun Zheng
    • Shichu Xiao
    • Pengfei Luo
    • Rongju Sun
    • Jun Liu
    • Zhaofan Xia
  • View Affiliations

  • Published online on: April 29, 2021     https://doi.org/10.3892/mmr.2021.12127
  • Article Number: 488
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

A hypertrophic scar (HPS) is characterized by abnormal cell proliferation and the overproduction of extracellular matrix. Currently, the treatment options available for this remain unsatisfactory. Innovative treatments are required to attenuate or prevent hypertrophic scarring and the present study searched for a drug capable of becoming a new preventative and therapeutic strategy. Although the underlying mechanisms have not been fully clarified; it is widely accepted that the TGF‑β1/SMAD3 signaling pathway serves an essential role in HPS formation. In the present study, a compound library consisting of clinically used drugs was screened for their inhibitory activity against the SMAD3 protein. The results indicated that ivermectin was able to suppress the phosphorylation of SMAD3. Therefore, the present study further investigated whether ivermectin exhibited antifibrotic effects on HPS fibroblasts. The results demonstrated that ivermectin inhibited the proliferation of HPS fibroblasts and significantly decreased the production of type I collagen, α‑smooth muscle actin and cellular communication network factor 2, as determined by analyzing the mRNA and protein expression levels. In conclusion, the results of the present study suggested that ivermectin may be a promising therapeutic agent for HPS.

Related Articles

Journal Cover

July-2021
Volume 24 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tian S, Zheng Y, Xiao S, Luo P, Sun R, Liu J and Xia Z: Ivermectin inhibits cell proliferation and the expression levels of type I collagen, α‑SMA and CCN2 in hypertrophic scar fibroblasts. Mol Med Rep 24: 488, 2021
APA
Tian, S., Zheng, Y., Xiao, S., Luo, P., Sun, R., Liu, J., & Xia, Z. (2021). Ivermectin inhibits cell proliferation and the expression levels of type I collagen, α‑SMA and CCN2 in hypertrophic scar fibroblasts. Molecular Medicine Reports, 24, 488. https://doi.org/10.3892/mmr.2021.12127
MLA
Tian, S., Zheng, Y., Xiao, S., Luo, P., Sun, R., Liu, J., Xia, Z."Ivermectin inhibits cell proliferation and the expression levels of type I collagen, α‑SMA and CCN2 in hypertrophic scar fibroblasts". Molecular Medicine Reports 24.1 (2021): 488.
Chicago
Tian, S., Zheng, Y., Xiao, S., Luo, P., Sun, R., Liu, J., Xia, Z."Ivermectin inhibits cell proliferation and the expression levels of type I collagen, α‑SMA and CCN2 in hypertrophic scar fibroblasts". Molecular Medicine Reports 24, no. 1 (2021): 488. https://doi.org/10.3892/mmr.2021.12127